tiprankstipranks
Trending News
More News >
Prothena downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe FlyProthena downgraded to Neutral from Overweight at Cantor Fitzgerald
10d ago
Prothena’s Hold Rating: Clinical Trial Challenges and Financial Pressures
Premium
Ratings
Prothena’s Hold Rating: Clinical Trial Challenges and Financial Pressures
10d ago
Prothena price target lowered to $81 from $110 at Piper Sandler
Premium
The Fly
Prothena price target lowered to $81 from $110 at Piper Sandler
10d ago
Prothena downgraded to Hold from Buy at Jefferies
PremiumThe FlyProthena downgraded to Hold from Buy at Jefferies
11d ago
Prothena downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Prothena downgraded to Perform from Outperform at Oppenheimer
11d ago
Prothena Discontinues Birtamimab Development After Trial Failure
Premium
Company Announcements
Prothena Discontinues Birtamimab Development After Trial Failure
14d ago
Prothena price target lowered to $30 from $48 at H.C. Wainwright
PremiumThe FlyProthena price target lowered to $30 from $48 at H.C. Wainwright
28d ago
Prothena price target lowered to $78 from $80 at Citizens JMP
Premium
The Fly
Prothena price target lowered to $78 from $80 at Citizens JMP
28d ago
Prothena Corporation Reports Q1 2025 Financial Results
Premium
Company Announcements
Prothena Corporation Reports Q1 2025 Financial Results
29d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100